96 related articles for article (PubMed ID: 1411633)
1. Neoadjuvant therapy for cervical cancer.
Kuehnle H; Meerpohl HG; Eiermann W; Achterrath W
Semin Oncol; 1992 Feb; 19(1 Suppl 2):94-8. PubMed ID: 1411633
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix.
Filtenborg TA; Hansen HH; Aage Engelholm S; Rørth M
Ann Oncol; 1993 Jun; 4(6):485-8. PubMed ID: 8353091
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
Koensgen D; Sehouli J; Belau A; Weiss M; Stope MB; Grokopf V; Eichbaum M; Ledwon P; Lichtenegger W; Zygmunt M; Köhler G; Mustea A
Int J Gynecol Cancer; 2017 Mar; 27(3):500-506. PubMed ID: 28187089
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer.
Kühnle H; Meerpohl HG; Eiermann W; Röben S; Lenaz L; Achterrath W
Cancer Chemother Pharmacol; 1990; 26 Suppl():S33-5. PubMed ID: 2189594
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.
Zanetta G; Lissoni A; Pellegrino A; Sessa C; Colombo N; Gueli-Alletti D; Mangioni C
Ann Oncol; 1998 Sep; 9(9):977-80. PubMed ID: 9818071
[TBL] [Abstract][Full Text] [Related]
8. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
9. Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Postmus PE; Smit EF; Berendsen HH; Haaxma-Reiche H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):17-23. PubMed ID: 1329219
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Lund B; Hansen OP; Hansen HH; Hansen M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. A phase II trial.
Cervellino JC; Araujo CE; Sánchez O; Miles H; Nishihama A
Acta Oncol; 1995; 34(2):257-9. PubMed ID: 7718266
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix.
Vallejo CT; Pérez JE; Domínguez ME; Leone BA; Machiavelli MR; Lacava JA; Romero AO; Ortiz EH; Grasso S; Amato S; Rodríguez R; Barbieri M; Romero Acuña J; Focaccia G; Suttora G; Scenna M; Boughen JM; Romero Acuña LA; Langhi MJ
Am J Clin Oncol; 2000 Oct; 23(5):481-6. PubMed ID: 11039508
[TBL] [Abstract][Full Text] [Related]
15. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
16. Gynecologic Oncology Group experience with ifosfamide.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1990 Apr; 17(2 Suppl 4):6-10. PubMed ID: 2159188
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant chemotherapy of cervix carcinoma--results of a phase II study].
Blohmer JU; Paepke S; Böhmer D; Ernhardt B; Sehouli J; Elling D; Lichtenegger W
Zentralbl Gynakol; 2001 May; 123(5):286-91. PubMed ID: 11449622
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of chemotherapy regimen using ifosphamide and carboplatin on recurrent or refractory neuroblastoma].
Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1550-2. PubMed ID: 17166384
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Adcock L; Webster KD; DeEulis T
Invest New Drugs; 1989 Nov; 7(4):341-3. PubMed ID: 2513286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
